2-hydroxypyridine has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Huang, W; Huang, X; Ou, C; Shao, J; Si, W; Tang, Y; Wang, P; Wu, M; Xiao, W | 1 |
| Fioravanti, R; Mai, A; Stazi, G; Valente, S; Zwergel, C | 1 |
| Arion, VB; Hanif, M; Hartinger, CG; Henke, H; Jakupec, MA; Kandioller, W; Keppler, BK; Kraatz, HB; Labib, M; Martic, S; Meier, SM | 1 |
1 review(s) available for 2-hydroxypyridine and Benign Neoplasms
| Article | Year |
|---|---|
Six Years (2012-2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2-Pyridone Compounds.
Topics: Bridged Bicyclo Compounds; Clinical Trials as Topic; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Indoles; Isoquinolines; Neoplasms; Pyridones; S-Adenosylmethionine | 2018 |
2 other study(ies) available for 2-hydroxypyridine and Benign Neoplasms
| Article | Year |
|---|---|
2-Pyridone-functionalized Aza-BODIPY photosensitizer for imaging-guided sustainable phototherapy.
Topics: Animals; Biocompatible Materials; Boron Compounds; Cell Survival; Fluorescent Dyes; HeLa Cells; Humans; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Permeability; Photochemotherapy; Photosensitizing Agents; Pyridones; Singlet Oxygen; Tissue Distribution | 2018 |
Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?
Topics: Amino Acids; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Cyclin-Dependent Kinase 2; Cytochromes c; DNA; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neoplasms; Osmium Compounds; Pyridones; Ruthenium Compounds; Ubiquitin | 2010 |